Log In Sign up
The largest database of trusted experimental protocols

In vivo mab anti mouse il 17a clone 17f3

Manufactured by BioXCell
Visit Supplier
Sourced in United States

In Vivo MAb anti-mouse IL-17A (clone: 17F3) is a laboratory reagent used for research purposes. It is a monoclonal antibody that specifically binds to the mouse interleukin-17A (IL-17A) protein.

Automatically generated - may contain errors

Lab products found in correlation

Spelling variants of this product

Anti-IL-17A (clone 17F3, (12 citations) Clone 17F3, (5 citations) IL-17A (5 citations) Anti–IL-17A mAb (clone 17F3; (4 citations) Anti-IL-17a (17F3, (4 citations) Anti-IL-17A (3 citations) Anti-mouse IL-17A clone 17F3 (2 citations) Anti-mouse IL-17A (17F3 (2 citations)

2 protocols using in vivo mab anti mouse il 17a clone 17f3

1

Anti-IL-17A Treatment in AOM/DSS Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
BALB/c or STAT1-/- mice were treated with 200 μg of In Vivo MAb anti-mouse IL-17A (clone: 17F3) (Bio X Cell, Lebanon, NH, USA), on days 7, 9, 11, 13, 15, 17, and 19 after AOM/DSS treatment and the control groups were treated with a similar concentration of isotype control via the intraperitoneal route.
Delgado-Ramirez Y., Baltazar-Perez I., Martinez Y., Callejas B.E., Medina-Andrade I., Olguín J.E., Delgado-Buenrostro N.L., Chirino Y.I., Terrazas L.I, & Leon-Cabrera S. (2021). STAT1 Is Required for Decreasing Accumulation of Granulocytic Cells via IL-17 during Initial Steps of Colitis-Associated Cancer. International Journal of Molecular Sciences, 22(14), 7695.
+ Open protocol
+ Expand
2

STAT1-/- Mice Treated with Anti-IL-17A

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the in vivo antibody administration, STAT1−/− mice with similar sized tumors were selected, divided into 2 groups. One group was treated with 200µg of InVivo MAb anti-mouse IL-17A (clone: 17F3), Bio X Cell, (Lebanon, NH, USA) and the second group was treated with a similar concentration of isotype control every alternate day for 2 weeks via intraperitoneal route.
Varikuti S., Oghumu S., Elbaz M., Volpedo G., Ahirwar D.K., Alarcon P.C., Sperling R.H., Moretti E., Pioso M.S., Kimble J., Nasser M.W., Ganju R.K., Terrazas C, & Satoskar A.R. (2017). STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade. Oncoimmunology, 6(11), e1361088.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!